tiprankstipranks
Neurotech International Ltd. (AU:NTI)
ASX:NTI
Australian Market

Neurotech International Ltd. (NTI) Share Price & Analysis

2 Followers

NTI Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.03 - AU$0.13
Previous CloseAU$0.1
Volume1.01M
Average Volume (3M)2.34M
Market Cap
AU$87.15M
Enterprise ValueAU$85.26M
Total Cash (Recent Filing)AU$1.90M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-16.4
Beta1.02
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume4,753,775
30 Day Avg. Volume2,343,535
Standard Deviation0.34
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.94%0.00%0.00%93.06%
0.00% Other Institutional Investors
93.06% Public Companies and
Individual Investors

NTI FAQ

What was Neurotech International Ltd.’s price range in the past 12 months?
Neurotech International Ltd. lowest share price was AU$0.03 and its highest was AU$0.13 in the past 12 months.
    What is Neurotech International Ltd.’s market cap?
    Currently, no data Available
    When is Neurotech International Ltd.’s upcoming earnings report date?
    Neurotech International Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 115 days.
      How were Neurotech International Ltd.’s earnings last quarter?
      Neurotech International Ltd. released its earnings results on Feb 26, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
        Is Neurotech International Ltd. overvalued?
        According to Wall Street analysts Neurotech International Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Neurotech International Ltd. pay dividends?
          Neurotech International Ltd. does not currently pay dividends.
          What is Neurotech International Ltd.’s EPS estimate?
          Neurotech International Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Neurotech International Ltd. have?
          Neurotech International Ltd. has 917,388,600 shares outstanding.
            What happened to Neurotech International Ltd.’s price movement after its last earnings report?
            Neurotech International Ltd. reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.333%.
              Which hedge fund is a major shareholder of Neurotech International Ltd.?
              Currently, no hedge funds are holding shares in AU:NTI
              ---

              Company Description

              Neurotech International Ltd.

              Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activity of the firm is functioned through the region of Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              MedAdvisor Limited
              LBT Innovations Limited
              Micro-X Ltd.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis